New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

NYU College of Nursing Receives $4.2M NIH/NIDA Grant to Study Testing and Linkage to Care Among Injecting Drug Users in Kenya

October 28, 2011
N-94, 2011-12

New York University College of Nursing (NYUCN) received a five-year, $4,161,665.00 grant from the National Institute of Health’s National Institute on Drug Abuse (NIH/NIDA) to research “Test and Linkage to Care Among Injecting Drug Users (TLC_IDU) Kenya.”    Principal Investigator Ann Kurth notes HIV infections in sub-Saharan Africa increasingly occur among injecting drug users (IDUs), a most-at-risk population (MARP). Evidence-based services for IDUs such as needle and syringe exchange programs (NSPs), opiod substitution therapy (OST), and IDU-specific antiretroviral therapy (ART) adherence support have been non-existent in this region.

“Kenya is conducting size estimations of IDUs and is preparing to launch the first-ever needle syringe program in Africa,” said NYUCN Professor Ann Kurth, PhD, CNM, RN.  “Our team of Kenyan policy leaders, addiction/behavioral scientists and modelers will leverage Kenya’s new program  to seek out IDUs, deliver rapid HIV testing, point of care CD4 count and link to antiretroviral therapy (ART), and evaluate community viral load in Nairobi and coastal Mombasa, where most IDUs in Kenya reside,” she said.

The grant’s co-PI is Dr. Peter Cherutich, of  the Kenya National AIDS & STD Control Programme.

The study’s goals are as follows:

Aim 1: Evaluate seek test treat retain – ‘Testing & Linkage to Care for IDUs’ (TLC-IDU Kenya) – using a stepped wedge cluster-randomized design. Clusters will be at a  planned n=25 IDU/MARP service sites. The teams will initiate respondent-driven sampling (RDS) to reach IDUs in Nairobi and Mombasa for baseline HIV-1 prevalence determination, then collect seven waves of study data as service sites roll out, including behavioral data on PDAs.

Teams will do rapid HIV testing and refer for addiction/mental health. HIV-positive persons will receive prevention with positives (PwP) counseling and point of care CD4 counts. Those with CD4 <350/μL will be assigned a peer case manager to link the person to ART at study-participating HIV clinics, support ART and PwP adherence and care retention.

Both peer case managers and subjects will receive small conditional cash transfers for subject’s adherence to HIV care visits. Primary study outcomes will include time to successful linkage to care, time to ART, and community viral load before and after the TLC-IDU initiation. ‘Community viral load’ will be ascertained by collecting specimens from around nine  randomly-selected HIV-positives at each of the 25 sites. This sampling will be done in eight waves over time, to document changes in infectivity (median viral load).  This will give good power to detect HIV viral load changes when comparing pre- and post-intervention periods..

Aim 2: Conduct mathematical modeling to estimate community viral load in IDU injecting and sexual networks, and to assess potential population-level impact of the TLC-IDU intervention on numbers of infections averted,and quality-adjusted life expectancy.

Aim 3: Assess the incremental cost-effectiveness ratio of the TLC-IDU model, using a national payer perspective.

This study will provide among the world’s first data regarding implementation of the seek, test, treat and retain paradigm with IDUs in sub-Saharan Africa. It will demonstrate the degree to which a combination of structural, biomedical and behavioral interventions can reduce infectivity.

“Partnership with Kenya’s national HIV program will allow lessons learned from this study to inform other countries considering how best to address the growing IDU contribution to the HIV epidemic in this high-HIV-burden region,” said Kurth.

About the New York University College of Nursing 
NYU College of Nursing is a global leader in nursing education, research, and practice. It offers a Bachelor of Science in Nursing; Master of Arts and Post-Master’s Certificate Programs; a Doctor of Philosophy in Research Theory and Development, and a Doctor of Nursing Practice degree.  For more information, visit www.nyu.edu/nursing.

This Press Release is in the following Topics:
College of Nursing, Research

Type: Press Release

Press Contact: Christopher James | (212) 998-6876

NYUCN Receives $4.2M NIH/NIDA Grant  to Study Testing and Linkage to Care Among Injecting Drug Users in Kenya

[Pictured Right] NYUCN Professor Ann Kurth, PhD, CNM, RN, observes field testing for HIV/AIDS


Search News



NYU In the News

Entrepreneurship Lab Opens at NYU

Crain’s New York Business covered the opening of the Mark and Debra Leslie Entrepreneurial eLab, which will be the headquarters for NYU’s Entrepreneurial Institute and all of the University’s programs aimed at promoting innovation and startups.

A Globalizer for N.Y.U. in Abu Dhabi

The New York Times profiled Bill Bragin who will become the first executive artistic director of NYU Abu Dhabi’s new performing arts center.

Think Tank to Ponder a Future for Ballet

The New York Times profiled Jennifer Homans, the director of NYU’s new Center for Ballet and the Arts.

The Brilliant Ten: Jonathan Viventi Builds Devices That Decode Thoughts

Popular Science named Assistant Bioengineering Professor Jonathan Viventi as one of its “brilliant ten” for his research into brain implants that could one day halt epileptic episodes:

Living and Leaving the Dream: Adrian Cardenas’ Journey from the Major Leagues to College

The New York Times ran a feature on Adrian Cardenas, a former major league baseball player who is now studying philosophy and creating writing at NYU.

NYU Footer